Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
about
Cytotoxic CD4 T cells in antiviral immunityThe Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza InfectionMHC Class II-Restricted Epitopes Containing an Oxidoreductase Activity Prompt CD4(+) T Cells with Apoptosis-Inducing PropertiesUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsCD4 T-cell immunotherapy for chronic viral infections and cancerHIV-1 Vaccine Trials: Evolving Concepts and DesignsDirect tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responsesCytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.High efficiency of antiviral CD4(+) killer T cellsTranscriptional analysis reveals gender-specific changes in the aging of the human immune system.Treating cutaneous squamous cell carcinoma using 5-aminolevulinic acid polylactic-co-glycolic acid nanoparticle-mediated photodynamic therapy in a mouse model.Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells.Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen.Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells.HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses.Rapid generation of NY-ESO-1-specific CD4(+) THELPER1 cells for adoptive T-cell therapy.Therapeutic Vaccine Strategies against Human Papillomavirus.Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections.Granzyme B- and Fas ligand-mediated cytotoxic function induced by mitogenic CD28 stimulation of human memory CD4+ T cellsPerforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection.Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic MechanismCellular and molecular immunology of lung cancer: therapeutic implications.Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3The Adjuvant Activity of Epimedium Polysaccharide-Propolis Flavone Liposome on Enhancing Immune Responses to Inactivated Porcine Circovirus Vaccine in Mice.Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotypeCytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection.Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes.Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates.Lineage re-commitment of CD4CD8αα intraepithelial lymphocytes in the gutUnraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.CD4 CTL: living up to the challenge.ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Prospects of a novel vaccination strategy for human gamma-herpesviruses.Cytolytic CD4(+) T cells in viral immunityImmunology of chronic myeloid leukemia: current concepts and future goals.Type 1 narcolepsy: a CD8(+) T cell-mediated disease?
P2860
Q21296742-1CA84F7F-3600-4176-87F0-46C514DACAE1Q26751016-678387A3-C6FA-4F74-9A54-749E342ED933Q26782899-F7A32029-5087-49C3-A091-428001D376F9Q26823898-017AEDAB-84B3-462E-ABC0-B1D384172CF5Q27022957-0AD428AC-4D6C-4071-8AD8-0B99AEA6813CQ30425520-BCC6FA63-FFDF-4190-8638-71BC358AA967Q30667174-BE4D768B-CB9F-4D62-8EE2-53FFD3C4F1CEQ34059488-C7DEE271-CD08-4B5B-9641-4841777569E9Q34399831-7F4DF6F7-06B6-4638-8460-27FCB134E763Q34658438-D6FF2FD1-6466-40F8-973E-694B5EEA1508Q34776449-BAF74B73-DB26-44C1-ADEA-C334D35D0DC6Q34945673-0977FCC8-CA85-46D8-8F47-8EFB48527A3FQ35106552-55A44A95-6104-497C-A0E3-8AD9A69EE0E8Q35192726-8CE20CAE-F98A-4463-9078-140C03B6A444Q35269599-207059BE-B42B-49FF-B782-E40498D6F22AQ35753766-0DCCAE6D-7DA7-406C-AD74-00BC9DB0D59EQ35799353-577439A5-9D3F-460A-AD4C-3FAA9A773024Q35826752-55E4CCAA-4AA3-4ABD-9D0B-E1EE23E0364DQ35836837-063B6515-84DA-457B-B535-A7EEF133D8EBQ35912982-4D58376E-F165-4F0B-93B3-60928BEFBD37Q36056478-0AF2D330-6AF3-4FDD-BA3E-F0208C89FF5CQ36075279-41B3F4AF-3891-4640-A222-2BFF3FADD220Q36130505-34CF8E6E-D02A-42D1-AEB3-842EB43D77AFQ36145913-DDD21316-49DF-478C-9E54-A7631270C5B1Q36155542-8B6B98A0-DAF3-4A04-A3E6-7F210DFC8E48Q36285370-D45ED8BA-E1F6-469D-AD6E-10D1F186C8ABQ36340873-879E56BE-5B2F-403D-AAB7-EA8B6EC259B8Q36434178-D8E9CF2C-D667-4F32-B167-09F62A3AD231Q36635015-40AEC1C0-7535-49A9-BC70-6F03D6EF4AA1Q36754331-AFAB1E90-1E0A-4BC0-922E-DCE5B15C1C14Q37021884-A7958966-6081-4D1D-9078-FF3208C0071EQ37414561-F1A7536B-9550-4AAD-8BF9-A15CEA479C71Q37457833-8B78CAAA-AEF6-4331-A1E6-5109798CB86DQ37512173-829A3F46-7712-4063-A5DB-65FDDAB73369Q37597931-9BAE528C-2E8D-45FA-91E9-AFD472384752Q37667998-647AA6C3-190B-4F21-91B3-2CD4419AF464Q37780705-F69EC2D5-15EE-4B13-B541-46C63F7D6125Q37812127-E5759942-D38C-44CE-A19C-2EDD3F9B9309Q38366539-4A28A226-0E32-4108-8EBD-22F5DEDEEF61Q38533728-4DF24A8D-74D0-4EF7-87C8-99B4E751400D
P2860
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
@en
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
@nl
type
label
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
@en
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
@nl
prefLabel
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
@en
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
@nl
P2860
P1433
P1476
Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
@en
P2093
Deborah M Brown
P2860
P356
10.1016/J.CELLIMM.2010.02.008
P577
2010-02-24T00:00:00Z